Drug Discovery Today
AUGUST 5, 2021
(Oslo, August 5, 2021) Molecular diagnostics specialist, Genetic Analysis AS (GA) today announced the first publication from the comprehensive HumGut microbiome database has appeared in the leading scientific journal Microbiome.
Medical Xpress
NOVEMBER 18, 2022
A comprehensive genomic analysis in more than 200 patients with metastatic urothelial carcinomas may help inform how a patient would respond to immunotherapy, report UNC Lineberger Comprehensive Cancer Center researchers and colleagues. About 90% of urothelial carcinomas are bladder cancers.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Scienmag
SEPTEMBER 10, 2020
Computational method capable of decoding influence of rare variants Geneticists could identify the causes of disorders that currently go undiagnosed if standard practices for collecting individual genetic information were expanded to capture more variants that researchers can now decipher, concludes new Johns Hopkins University research.
Scienmag
APRIL 26, 2022
In the most comprehensive genetic analysis of the native people there to date, researchers reveal that the ethnic groups’ peopling and migration history is more complex than previously concluded. China’s mountainous southwestern area is home to one of the country’s most ethnically diverse populations.
The Pharma Data
JANUARY 7, 2021
The new study brought together data from genomic prostate cancer studies around the world, including in the United States, Ghana, Japan, Sweden and the United Kingdom. The study — described as the most diverse genetic analysis for prostate cancer ever — included men of African, Asian, Hispanic and European ancestry.
Delveinsight
FEBRUARY 25, 2021
Cambridge, Massachusetts-based Beam aims to make more precise edits with genetic medicines, which employ base-editing. Instead of snipping the genome, base editing lets for edits of individual letters in a genetic sequence. Beam employs three approaches to deliver its genetic medicines to cells.
The Pharma Data
OCTOBER 27, 2020
.” The single-reaction panel targets five regions of the viral genome and provides excellent accuracy and sensitivity. “Most real time qPCR-based assays target only two or three targets on the viral genome.” “Most real time qPCR-based assays target only two or three targets on the viral genome.”
Expert insights. Personalized for you.
40 
Let's personalize your content